Retinoic Acid, all trans CAS: 302-79-4
MF: C20H28O2
MW: 300.4
An activator of RAR and RXR and used in stem cells.

Retinoic Acid, all trans (CAS 302-79-4)

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 128ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
5
1
4
0
3
0
2
0
1
0
Sinónimo: Vitamin A acid
Solicitud: An activator of RAR and RXR and used in stem cells
Número de CAS: 302-79-4
Pureza: ≥98%
Peso Molecular: 300.4
Fórmula Molecular: C20H28O2
Supplemental Information: This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
* En el Certificado de Análisis específico de lote, puede encontrar información específica (como el contenido en agua).
Envíe una reseña para este producto y reciba 15 créditos Cruz

Retinoic Acid, all trans is the oxidized carboxylic acid form of retinol, known in the dietary context as Vitamin A. Retinal (sc-210778) is the aldehyde form of retinol required by the retina of the eye for light absorption and visual processing. Retinoic acid and the other retinoids are involved in a broad range of biological regulations, mediating differentiation, proliferation, and apoptosis. Binding of Retinoic Acid to the nuclear receptors RAR (retinoic acid receptor) and the RXR (retinoid X receptor) initiate signals for transcription and development. The intimate relationship between retinoids and cell cycle regulation has been implicated in suppression of oncogenic proliferation. Also available in a photoactivatable, caged form (sc-202089).


References

1. Leid, M., et al., 1992. Multiplicity generates diversity in the retinoic acid signalling pathways. Trends in biochemical sciences. 17(10): 427-33. PMID: 1333659
2. Allenby, G., et al., 1994. Binding of 9-cis-retinoic acid and all-trans-retinoic acid to retinoic acid receptors alpha, beta, and gamma. Retinoic acid receptor gamma binds all-trans-retinoic acid preferentially over 9-cis-retinoic acid. The Journal of biological chemistry. 269(24): 16689-95. PMID: 8206989
3. Napoli, J L., et al., 1996. Biochemical pathways of retinoid transport, metabolism, and signal transduction. Clinical immunology and immunopathology. 80(3 Pt 2): S52-62. PMID: 8811064
4. Bushue, Nathan., et al., 2010. Retinoid pathway and cancer therapeutics. Advanced drug delivery reviews. 62(13): 1285-98. PMID: 20654663

Estado de Materia :
Solid
Solubilidad :
Soluble in DMSO (25 mg/mL), ethanol (10 mg/mL), acetate, DMF (20 mg/mL), dimethyl sulfoxide (25 mg/mL), chloroform (40 mg/mL), methanol, acetone (30 mg/mL), and dichloromethane. Insoluble in water, and ether. It is recommended that solutions be made fresh for each use.
ALMACENAMIENTO :
Store at -20° C
Punto de Fusión :
180-181° C (lit.)
Punto de ebullición :
~462.80° C at 760 mmHg (Predicted)
Densidad :
1.01 g/cm3
Indice de Refracción :
n20D 1.56
IC50 :
Retinoic acid receptor gamma: IC50 = 0.62 nM (human); Retinoic acid receptor alpha: IC50 = 5 nM (mus musculus); Herpesvirus 4: IC50 = 15.4 nM (human)
Datos Ki :
Retinoic acid receptor gamma: Ki= 0.7 nM (human); Retinoic acid receptor beta: Ki= 0.5 nM (human); Retinoic acid receptor alpha: Ki= 0.1 nM (human)
Valores de pK :
pKa: 4.73
Para Uso Exclusivo en Investigación. No está diseñado para uso en diagnosis o terapia.
WGK Alemania :
2
RTECS :
VH6475000
PubChem CID :
444795
Indice de Merck :
14: 8165
Número MDL :
MFCD00001551
Número EC :
206-129-0
Registro Beilstein :
2057223
SMILES :
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C

Descargar SDS (MSDS)

CERTIFICADO DE ANÁLISIS

Necesita Adobe Acrobat Reader para ver de forma fiable,
imprimir y comentar el documento de PDF

Retinoic Acid, all trans  Menciones del Producto

Ver como otros han utilizado Retinoic Acid, all trans. Haga click en la entrada de PubMed .

Citaciones 1 a 10 de un total de 12

PMID: # 29072505  Pastorková, B. et al. 2017. Drug Chem Toxicol. 41: 1-7.

PMID: # 26345577  Briceño, A. et al. 2016. Neurotox Res. 29: 381-93.

PMID: # 26898150  Venne, P. et al. 2016. J Chromatogr A. 1438: 57-64.

PMID: # 26208032  Illés, P. et al. 2015. J. Agric. Food Chem. 63: 7074-83.

PMID: # 20547768  Apostolatos, H. et al. 2010. J Biol Chem. -.

PMID: # 20096012  Britschgi, A. et al. 2010. Br. J. Haematol. 149: 55-64.

PMID: # 18511453  Wang, C. et al. 2008. J. Biochem. 144: 313-321.

PMID: # 18280257  Kiningham, KK. et al. 2008. Free Radic. Biol. Med. 44: 1610-1616.

PMID: # 17596541  Soriano, AO. et al. 2007. Blood. 110: 2302-2308.

PMID: # 17283134  Ohnuma-Ishikawa, K. et al. 2007. Cancer Res. 67: 1019-1029.

Citaciones 1 a 10 de un total de 12
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 112ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 8ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;

Santa Cruz Biotechnology, Inc. es un líder mundial en el desarrollo de productos para el mercado de la investigación biomédica. Llámenos gratis al 00 800 4573 8000.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved."Santa Cruz Biotechnology", y el logo de Santa Cruz Biotechnology, Inc., "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", el logo de San Juan Ranch, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", y "EZ Touch" son marcas registradas de Santa Cruz Biotechnology, Inc. Todas las marcas registradas son propiedad de su respectivo dueño.